Stephan Harbarth earned his medical degree from Ludwig-Maximilians-University in Munich in 1993 and completed his residency in internal medicine and tropical medicine at Munich University Hospitals. After serving as a clinical fellow in the Infectious Diseases Division and Infection Control Program in the Department of Internal Medicine at Geneva University Hospitals, Dr Harbarth completed his master’s degree in epidemiology at Harvard University in Boston. He is board certified in infectious diseases and was appointed associate professor at the University of Geneva in 2010. Dr Harbarth’s work has garnered several awards, including the ICAAC/ASM Young Investigator Award (2003), the Young Investigator Award from ESCMID (2006), the Swiss Society for Infectious Diseases Award for epidemiological research (2008, 2011), and the SHEA Investigator Award (2011). Dr Harbarth’s group is currently conducting several clinical and epidemiological studies to evaluate key questions related to the control of the acquisition, transmission and infection by multidrug-resistant microorganisms. They participate in several ongoing large-scale EU-funded studies to address this public health threat and collaborate closely with the Genomics Research Laboratory at HUG, based on a productive translational research platform. Stephan Harbarth earned his medical degree from Ludwig-Maximilians-University in Munich in 1993 and completed his residency in internal medicine and tropical medicine at Munich University Hospitals. After serving as a clinical fellow in the Infectious Diseases Division and Infection Control Program in the Department of Internal Medicine at Geneva University Hospitals, Dr Harbarth completed his master’s degree in epidemiology at Harvard University in Boston. He is board certified in infectious diseases and was appointed associate professor at the University of Geneva in 2010. Dr Harbarth’s work has garnered several awards, including the ICAAC/ASM Young Investigator Award (2003), the Young Investigator Award from ESCMID (2006), the Swiss Society for Infectious Diseases Award for epidemiological research (2008, 2011), and the SHEA Investigator Award (2011). Dr Harbarth’s group is currently conducting several clinical and epidemiological studies to evaluate key questions related to the control of the acquisition, transmission and infection by multidrug-resistant microorganisms. They participate in several ongoing large-scale EU-funded studies to address this public health threat and collaborate closely with the Genomics Research Laboratory at HUG, based on a productive translational research platform.

fermentation